Questcor Pharmaceuticals, Inc. Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Apr 30 Calls Today's Calls

Call Details Questcor Pharmaceuticals, Inc. Earnings Conference Call (Q1 2008) Wed, Apr 30, 2008, 11:00 am Eastern Listen to the archived event audio About Questcor Pharmaceuticals, Inc. (NasdaqCM:QCOR) Questcor Pharmaceuticals, Inc. focuses on developing and commercializing pharmaceutical drugs primarily in the United States. It owns and markets two products, H.P. Acthar Gel and Doral. The company’s H.P. Acthar Gel, a repository corticotropin injection drug, is used for the treatment of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis. H.P. Acthar Gel is also used in treating patients with infantile spasms, a rare form of refractory childhood epilepsy; and opsoclonus myoclonus syndrome, a rare autoimmune-related childhood neurological disorder. Its Doral is used for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. The company also involves in developing new medications, including QSC-001, an orally disintegrating tablet formulation of hydrocodone bitartrate and acetaminophen for the treatment of moderate to moderately severe pain in patients with swallowing difficulties. Questcor Pharmaceuticals was founded in 1990 and is headquartered in Union City, California. More Info: Quote | Profile | Reports | Research